Ex parte DUAN et al. - Page 4




          Appeal No. 97-2174                                                           
          Application No. 08/214,763                                                   

          term “reproducible dosing” is expressly defined at lines 4                   
          through 7 of specification page 10.  Under these                             
          circumstances, we perceive no basis with the examiner’s view                 
          that “so quickly” renders appealed independent claim 1 and the               
          claims which depend therefrom indefinite.                                    
               For the above stated reasons, we cannot sustain the                     
          examiner’s section 112, second paragraph, rejection of claims                
          1 through 24.                                                                
               Concerning the section 103 rejection, the examiner argues               
          “it would be obvious to one of ordinary skill in the art to                  
          substitute the dispersing agent of WO 92/00062 [i.e., Moris]                 
          with the ester of JP 4,169,554 [i.e., the Japanese reference]                
          and obtain the claimed aerosol; the motivation to do so being                
          from the disclosure that the ester(s) of JP 4,169,554 show                   
          excellent mutual solubility/compatibility with 1,1,1,2-                      
          tetrafluoroethane, which is also the propellant of WO                        
          92/00062” (answer, pages 3-4).  The appellants are correct,                  
          however, that the solubility referred to in the Japanese                     
          reference plainly would not have motivated “one of ordinary                  
          skill in the art to substitute the dispersing agent of WO                    
          92/00062 with the ester of JP 4,169,554” as proposed by the                  

                                          4                                            





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007